Articles tagged with: STIs

Feb26

FROM THE PIPELINE | The road to female controlled prevention: The female condom as a currently available MPT

Monday, 26 February 2018 Written by // Denise Van Dijk Series // From the Pipeline Tags // condoms, contraception, FC2, female condom, HIV, pipeline, prevention, product, STIs, women

The Road

6 years; 12 Million Dollars.

When the founders of the Female Health Company (FHC) began conceptualizing the female condom in 1996, they wanted to create a product that would impact society as well as benefit investors. Little did they know that it would be a long road to develop a market for the female condom.

Feb14

Striving for a worry-free Valentine's Day...and every other day

Wednesday, 14 February 2018 Written by // Kathreen Daria Tags // college, HIV, pregnancy, protection, reproductive health, STIs, valentine's day, women

“It finally happened! We had sex! And how romantic that it was on Valentine’s Day, right?” Jen, one of the first friends I made in college, could barely contain herself as she shared this news while walking with me to the university café. She then hesitated, “The only thing is, he didn’t have a condom. Do you think I’ll be okay?”

Nov29

Status of the field: MPTs in the product pipeline

Wednesday, 29 November 2017 Written by // IMPT Secretariat Staff Tags // contraception, prevention, product development, STIs, women

Since 2009, when MPTs officially became a “thing,” we have had a lot of conversations about MPTs and answered even more questions. We have spoken with friends, family, colleagues, neighbors, seatmates on plane flights – you name it. Until recently, not many people had heard of MPTs, and we spent a large part of these conversations doing quite a bit of explaining.

Most people we talk to seem universally on board with the concept of MPTs, thinking that it “just makes sense” as a prevention approach. However, because there aren’t many ready-to-use MPTs on the market (condoms being the sole exception) they are also hesitant to get “too excited” about future products still in development. For many, MPTs sound great – but intangible, disconnected from reality.

Nov02

Will you join us?

Thursday, 02 November 2017 Written by // IMPT Secretariat Staff Tags // HIV, innovation, prevention, product, reproductive health, SRH, STIs, women

It remains unacceptable that women and girls worldwide continue to confront preventable sexually transmitted infections (STIs), including HIV, as well as face high rates of unintended pregnancies. It is unacceptable that advocates, scientists, and politicians still need to convince people that investing in, innovating around, and creating a supportive policy environment for women’s health is imperative. Public health figures should speak for themselves –  women need access, innovation, more options for disease and pregnancy prevention. It has been nearly 40 years since the emergence of the HIV/AIDS epidemic, 60 years since the first birth control pill became available, and 90 years since penicillin was discovered and became a successful treatment for bacterial STIs. While many critical advances have been made in the decades following these sexual and reproductive health milestones, the continued suffering of millions of women worldwide means that we, as a public health community, need to do better.

<<  1 [2
The IMPT is the first & only initiative dedicated to advancing the field of multipurpose prevention technologies (MPTs), products that combine HIV prevention, other STI prevention, and contraception.

IMPT Secretariat
1750 Howe Avenue, Suite 550
Sacramento, CA 95825
IMPT@cami-health.org

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
© Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.